President's Welcome

Dear Colleagues,


Thank you for the honor to serve as President of the Association for Molecular Pathology (AMP). Belonging to AMP and participating in the association’s initiatives and leadership opportunities has enabled me to work along our members in the development of our field, and I am proud to have been an AMP member for nearly fifteen years.

AMP is able to bring together the diverse group of individuals serving patients through molecular diagnostics; we are molecular pathologists, clinical laboratorians, technologists, clinical or basic research scientists, reagent/instrument manufacturers, academic and commercial laboratories, bioinformaticists, teachers, mentors, students and public servants. Together, we promote the highest quality of molecular diagnostics to improve patient care.

Since 1995, AMP has served as the premier organization representing the field of molecular diagnostics and molecular medicine. We are known for our tireless advocacy efforts on behalf of patients and our community, our comprehensive catalog of educational offerings, The Journal of Molecular Diagnostics, our highly regarded research journal, and for the community of experts that comprise the body of AMP members.

The AMP annual meeting is the premiere gathering place where all aspects of new molecular testing are first discussed. In 2016 the AMP meeting hosted more than 2000 attendees from 28 countries, under the maxim: “Big World. Molecular Medicine. One Community.” This year, we build upon this goal by hosting our first ever AMP Global Congress on Molecular Pathology (GCMP) in Berlin, Germany, an effort developed in collaboration with our International Affiliates. This meeting will bring together molecular professionals from all over the world to showcase the latest in molecular diagnostic technologies and clinical applications.

I am proud for the role that AMP has played in fostering the growth of molecular and precision medicine. AMP strives to advance the clinical practice, science, and excellence of molecular and genomic laboratory medicine through education, innovation, and advocacy to enable highest quality health care. If I have just described your professional priorities, become a member and experience all that AMP has to offer!



Federico A. Monzon, MD, President
Castle Biosciences

Corporate Partners